Wellapy is a clinically validated digital therapeutic (DTx) for obesity treatment, developed by Lifeness – a Norwegian health technology company headquartered in Tromsø and Oslo. As a CE-marked medical device prescribed by physicians, Wellapy delivers personalised treatment through AI-driven nutrition guidance, adaptive physical activity programmes, and evidence-based behavioural change therapy. The solution is available on iOS and Android, supported by a clinical dashboard. Supported by multiple clinical studies, Wellapy represents a scalable, first-line digital intervention designed for public reimbursement and European market expansion.